Orthofix partners with LimaCorporate on hip dislocation solution

Orthofix’s Fitbone system. [Image from Orthofix]Orthofix Medical (Nasdaq:OFIX) announced today that it entered into a licensing partnership for the U.S. market with LimaCorporate.

The licensing partnership aims to provide a novel solution for patients with the challenging condition of chronic high dislocation of the hip. It will combine the limb-lengthening technology of Orthofix’s Fitbone intramedullary nail system with LimaCorporate’s proprietary, patient-specific, 3D-printed pelvic fixation device.

Lewisville, Texas-based Orthofix said in a news release that, once surgically implanted, the devices work together with the aim of allowing surgeons to distract the femur to an anatomically correct position, allowing for the correction of the leg-length discrepancy, reducing strain on the spine and allowing for a total hip replacement to follow.

The new solution currently does not have FDA clearance and is only available through an FDA compas…

Read more
  • 0